Showing results (31-40 of 119) with videos related to
Sort By:
Pageof 12
Bulletin De La Societe De Pathologie Exotique (1990)|January 1, 1993
[Clinical value of C-reactive protein, alpha 1-glycoprotein acid and transferrin assay in homozygous sickle cell disease]D Monnet, I Diallo, A Sangare, et al.Journal of Crohn'S & Colitis|April 22, 2015
Combination of C-reactive protein, infliximab trough levels, and stable but not transient antibodies to infliximab are associated with loss of response to infliximab in inflammatory bowel diseaseX Roblin, H Marotte, M Leclerc, et al.The Veterinary Record|September 14, 2010
Estimated prevalence of Mycobacterium avium subspecies paratuberculosis infection in herds of dairy goats in FranceP Mercier, C Baudry, F Beaudeau, et al.Journal of Dairy Science|June 22, 2024
Dairy goat doe-kid rearing systems: Farmers' motivations and a description of practices, benefits, and drawbacksM Berthelot, C Aubert, N Ehrhardt, et al.Hepatology (Baltimore, Md.)|December 1, 1994
Phenobarbital induction of alpha 1-acid glycoprotein in primary rat hepatocyte culturesT Fournier, N Mejdoubi, D Monnet, et al.Journal of Immunological Methods|November 30, 1984
An immunochemical procedure to evaluate the degree of desialylation of alpha 1-acid glycoprotein in rat serumD Biou, D Monnet, F Millet, et al.Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1985
[Modification of the saccharide structures of orosomucoid in rats stimulated by treatment with phenobarbital]D Monnet, J Feger, D Biou, et al.Journal Francais D'Ophtalmologie|October 31, 2003
[Loss of visual acuity due to choroidal ischemia in Fabry's disease]J-M Guenoun, C Parc, D Monnet, et al.BMC Gastroenterology|June 21, 2017
Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literatureC Venturin, S Nancey, P Danion, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 8, 2025
Impact of immediate drug optimization of ustekinumab on medium term targets in Crohn's disease: results from the multicentre retrospective real-life study MUSTM Hupé, A Abdelmoula, T Chateau, et al.Pageof 12